UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice

Bone (New York, N.Y.), 2015-09, Vol.78, p.216-224

2015

Volltextzugriff (PDF)

Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis?

Osteoporosis international, 2020-12, Vol.31 (12), p.2271-2286

2020

Volltextzugriff (PDF)

Reflections from the OARSI 2022 clinical trials symposium: The pain of OA—Deconstruction of pain and patient-reported outcome measures for the benefit of patients and clinical trial design

Osteoarthritis and cartilage, 2023-10, Vol.31 (10), p.1293-1302

2023

Volltextzugriff (PDF)

Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis

Bone (New York, N.Y.), 2008-05, Vol.42 (5), p.841-847

2008

Volltextzugriff (PDF)

Management of Glucocorticoid-Induced Osteoporosis

Calcified tissue international, 2012-10, Vol.91 (4), p.225-243

2012

Volltextzugriff (PDF)

Adherence to treatment of osteoporosis : a need for study

Osteoporosis international, 2007-10, Vol.18 (10), p.1311-1317

2007

Volltextzugriff (PDF)

Biomarkers and personalised medicine in rheumatoid arthritis: a proposal for interactions between academia, industry and regulatory bodies

Annals of the Rheumatic Diseases, 2011-10, Vol.70 (10), p.1713-1718

2011

Volltextzugriff (PDF)

Gut microbiota and osteoarthritis management: An expert consensus of the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO)

Ageing research reviews, 2019-11, Vol.55, p.100946-100946, Article 100946

2019

Volltextzugriff (PDF)

Total joint replacement of hip or knee as an outcome measure for structure modifying trials in osteoarthritis

Osteoarthritis and cartilage, 2005, Vol.13 (1), p.13-19

2005

Volltextzugriff (PDF)

Practical guidance for engaging patients in health research, treatment guidelines and regulatory processes: results of an expert group meeting organized by the World Health Organization (WHO) and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)

Aging clinical and experimental research, 2019-07, Vol.31 (7), p.905-915

2019

Volltextzugriff (PDF)

Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature Review

Calcified tissue international, 2019-08, Vol.105 (2), p.109-124

2019

Volltextzugriff (PDF)

Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science

Osteoporosis international, 2008-09, Vol.19 (9), p.1247-1250

2008

Volltextzugriff (PDF)

Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis

Advances in therapy, 2019-10, Vol.36 (10), p.2811-2824

2019

Volltextzugriff (PDF)

Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Epidemiology and Phenotype of Osteoarthritis

Drugs & aging, 2015-03, Vol.32 (3), p.179-187

2015

Volltextzugriff (PDF)

Practical guidance for patient-centred health research

The Lancet (British edition), 2019-03, Vol.393 (10176), p.1095-1096

2019

Volltextzugriff (PDF)

Antidepressant medications and osteoporosis

Bone (New York, N.Y.), 2012-09, Vol.51 (3), p.606-613

2012

Volltextzugriff (PDF)

Address in Portuguese and Spanish: Studies in Diachrony and Diachronic Reconstruction

2020

Volltextzugriff (PDF)

Achieving equal and timely access to innovative anticancer drugs in the European Union (EU): summary of a multidisciplinary CECOG-driven roundtable discussion with a focus on Eastern and South-Eastern EU countries

ESMO open, 2019, Vol.4 (6), p.e000550-e000550, Article e000550

2019

Volltextzugriff (PDF)

Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science

Osteoporosis international, 2009-03, Vol.20 (3), p.497-498

2009

Volltextzugriff (PDF)

Proteolytic processing of chromogranins

Advances in experimental medicine and biology, 2000, Vol.482, p.155

2000

Volltextzugriff (PDF)

The use of placebo-controlled and non-inferiority trials for the evaluation of new drugs in the treatment of postmenopausal osteoporosis

Osteoporosis international, 2002-01, Vol.13 (1), p.1-5

2002

Volltextzugriff (PDF)

Regulation of chromogranin biosynthesis by neurotrophic growth factors in neuroblastoma cells

Neurochemistry international, 2001, Vol.38 (1), p.43-52

2001

Volltextzugriff (PDF)

1 – 25 von 278

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(259)
Mit Volltextzugriff
(241)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice

Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis?

Reflections from the OARSI 2022 clinical trials symposium: The pain of OA—Deconstruction of pain and patient-reported outcome measures for the benefit of patients and clinical trial design

Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis

Management of Glucocorticoid-Induced Osteoporosis

Adherence to treatment of osteoporosis : a need for study

Biomarkers and personalised medicine in rheumatoid arthritis: a proposal for interactions between academia, industry and regulatory bodies

Gut microbiota and osteoarthritis management: An expert consensus of the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO)

Total joint replacement of hip or knee as an outcome measure for structure modifying trials in osteoarthritis

Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature Review

Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science

Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis

Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Epidemiology and Phenotype of Osteoarthritis

Recommendations for an update of the current (2001) regulatory requirements for registration of drugs to be used in the treatment of osteoporosis in postmenopausal women and in men

Practical guidance for patient-centred health research

Antidepressant medications and osteoporosis

Address in Portuguese and Spanish: Studies in Diachrony and Diachronic Reconstruction

Achieving equal and timely access to innovative anticancer drugs in the European Union (EU): summary of a multidisciplinary CECOG-driven roundtable discussion with a focus on Eastern and South-Eastern EU countries

Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science

Proteolytic processing of chromogranins

Correction to: Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature Review (Calcified Tissue International, (2019), 105, 2, (109-124), 10.1007/s00223-019-00561-w)

The use of placebo-controlled and non-inferiority trials for the evaluation of new drugs in the treatment of postmenopausal osteoporosis

Regulation of chromogranin biosynthesis by neurotrophic growth factors in neuroblastoma cells

Suchergebnisse filtern